Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2
Detection Principle
NucleicAcid-PCR based
Target
E and N2 genes
Testing Method Category
PCR_KIT
Testing Method
Xpert Xpress SARS-CoV-2 assay
Testing Method - Additional Info
assessment of the use of posterior oropharyngeal saliva as specimens for the detection of SARS-CoV-2 in an automated point-of-care molecular assay
Reported Performance
detection rate: N2 (NPS 94.8%) (Saliva 93.1%); E (Saliva: 89.7%( (saliva: 82.8%)
Sample Size
58 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements